News Overview

Softtech Engineers Limited has informed the Exchange the Clarification with respect to Outcome of Board Meeting filed on 10th November, 2022 underRegulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

This has reference to the Board Meeting outcome filed on 04th November, 2022 intimating the declaration of 2nd Interim dividend of Rs. 8.50 per share. The record date for the same was fixed as 17th November 2022. We would like to inform that the payment of the dividend has been completed by credit to the eligible shareholders on 28th November 2022.

PTC India Limited has informed the Exchange about Closure of trading window

Poonawalla Fincorp Limited has informed the Exchange about Voting results, Scrutinizer report, Proceedings and Minutes of Postal Ballot

Sukhjit Starch & Chemicals Limited has informed the Exchange about Meeting of Board of Directors of the company is scheduled to be held on Monday, the 5th day of December, 2022 to, inter-alia, consider the following:1.Declaration of Interim Dividend for the financial year 2022-23. 2.Fixation of record date/ book closure for the payment of Interim Dividend, if declared by the Board.The Trading Window for dealing in the securities of the company will remain closed for all Directors, officers and designated employees of the company from tomorrow i.e 01/12/2022 and would open 48 Hrs. after the date of Board Meeting.

BoFA Securities India Limited has informed the Exchange about corrigendum to the Detailed Public Statement about Open offer for acquisition of Federal-Mogul Goetze (India) Limited by Pegasus Holdings III, LLC, together with PA.

On 2 December 2022

On 3 December 2022

Biocon Biologics, subsidiary of Biocon announced today that it has successfully completed its multi-billion-dollar (USD) acquisition of the global biosimilars business of its partner Viatris Inc. (NASDAQ: VTRS). Biocon Biologics and Viatris have obtained all applicable approvals from key global regulators including the U.S. Federal Trade Commission, the Competition Commission of India and the Reserve Bank of India, and its investors. Effective from the date […]

Union Bank of India has allotted Unsecured, Subordinated, Non-Convertible, Taxable, Fully Paid-Up Basel III Compliant Tier- 2 Bonds in the nature of Debentures eligible for inclusion in Tier 2 Capital (Bonds) in two tranches of Rs.1500 crore (ISIN: INE692A08219,Series XXXVI-A) and Rs.700 crore (ISIN: INE692A08201,Series XXXVI-B) aggregating to Rs.2200 crore on 29 November 2022.Powered by Capital Market – Live News